Wednesday, May 18, 2011

Hepatitis C African Americans, and INCIVEK


Hepatitis C is a viral infection that causes swelling and infection of the liver, and is particularly active within the African American Community, and at a level called "chronic," representing 22 percent of all known carriers in America.

How this infection spreads by simple blood-to-blood contact and is difficult, if in some cases impossible to detect early on.

Hepatitis C impacts an estimated 270 million to 300 million people Worldwide, 30,000 people in Santa Clara County and 12,000 people in San Francisco, and 2,400 new cases were reported in 2010.

An exciting new drug called INCIVEK, made by Vertex, is said to be the breakthrough drug of the future, today. Moreover, Vertex claims INCIVEK beats the current 40 percent to 45 percent cure rate; patients have a whopping 80 percent cure rate in clinical trials done thus far. But with all this, it's not a vaccine, and it's not yet approved by the FDA, but it reportedly increases the chance that someone undergoing treatment for HVC will be cured by the end of treatment.

This is an interesting - hell, exciting - new development that this blogger will be following in the coming weeks.

Stay tuned.
Enhanced by Zemanta

No comments:

Post a Comment